Transcription factors as readers and effectors of DNA methylation

Nature Reviews Genetics

Volumn 17, Issue 9, 2016, Pages 551-565

  Zhu, Heng ^a,b   Wang, Guohua ^c   Qian, Jiang ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN; TRANSCRIPTION FACTOR; DNA; DNA BINDING PROTEIN;

ARTICLE; BASE PAIRING; BINDING AFFINITY; BISULFITE SEQUENCING; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; DNA SPLICING; FUNCTIONAL PROTEIN MICROARRAY; GENE ACTIVATION; GENE REPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; IN VIVO STUDY; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN MICROARRAY; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

DNA; DNA METHYLATION; DNA-BINDING PROTEINS; HUMANS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84980361817     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg.2016.83     Document Type: Article

References (145)

1. Bestor, T. H. DNA methylation: evolution of a bacterial immune function into a regulator of gene expression and genome structure in higher eukaryotes. Phil. Trans. R. Soc. Lond. B 326, 179-187 (1990)
2. Bird, A. P., & Wolffe, A. P. Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454 (1999)
3. Jaenisch, R., & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245-254 (2003)
4. Goll, M. G., & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005)
5. Bestor, T. H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395-2402 (2000)
6. Hendrich, B., & Tweedie, S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 19, 269-277 (2003)
7. Law, J. A., & Jacobsen, S. E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 11, 204-220 (2010)
8. Suzuki, M. M., & Bird, A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465-476 (2008)
9. Krauss, V., & Reuter, G. DNA methylation in Drosophila-A critical evaluation. Prog. Mol. Biol. Transl. Sci. 101, 177-191 (2011)
10. Lyko, F., Ramsahoye, B. H., & Jaenisch, R. DNA methylation in Drosophila melanogaster. Nature 408, 538-540 (2000)
11. Takayama S., et al. Genome methylation in D. melanogaster is found at specific short motifs and is independent of DNMT2 activity. Genome Res. 24, 821-830 (2014)
12. Feng S., et al. Conservation and divergence of methylation patterning in plants and animals. Proc. Natl Acad. Sci. USA 107, 8689-8694 (2010)
13. Selker, E. U. Epigenetic phenomena in filamentous fungi: useful paradigms or repeat-induced confusion?. Trends Genet. 13, 296-301 (1997)
14. Jeon, J., et al. Genome-wide profiling of DNA methylation provides insights into epigenetic regulation of fungal development in a plant pathogenic fungus, Magnaporthe oryzae. Sci. Rep. 5, 8567 (2015)
15. Lister R., et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133, 523-536 (2008)
16. Bird, A. The essentials of DNA methylation. Cell 70, 5-8 (1992)
17. Jones, P. A., & Takai, D. The role of DNA methylation in mammalian epigenetics. Science 293, 1068-1070 (2001)
18. Robertson, K. D. DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610 (2005)
19. Jones, P. A., & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002)
20. Jones, P. A., & Baylin, S. B. The epigenomics of cancer. Cell 128, 683-692 (2007)
21. Jones, P. A., & Laird, P. W. Cancer epigenetics comes of age. Nat. Genet. 21, 163-167 (1999)
22. Laird, P. W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 (2003)
23. Li M., et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat. Biotechnol. 27, 858-863 (2009)
24. Gavin, D. P., & Sharma, R. P. Histone modifications, DNA methylation, and schizophrenia. Neurosci. Biobehav. Rev. 34, 882-888 (2010)
25. Jiang Y. H., et al. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet. A 131A, 1-10 (2004)
26. Nagarajan, R. P., Hogart, A. R., Gwye, Y., Martin, M. R., & LaSalle, J. M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1, e1-e11 (2006)
27. Lister R., et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013)
28. Lister R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009)
29. Meissner A., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770 (2008)
30. Doi, A., et al. Differential methylation of tissue-And cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353 (2009)
31. Irizarry R. A., et al. The human colon cancer methylome shows similar hypo-And hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009)
32. Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529-541 (2011)
33. Wade, P. A. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene 20, 3166-3173 (2001)
34. Hendrich, B., & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538-6547 (1998)
35. Zhang X. Y., et al. Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein. Nucleic Acids Res. 18, 6253-6260 (1990)
36. Saito, M., & Ishikawa, F. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem. 277, 35434-35439 (2002)
37. Zhang Y., et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935 (1999)
38. Springer, N. M., & Kaeppler, S. M. Evolutionary divergence of monocot and dicot methyl-CpG-binding domain proteins. Plant Physiol. 138, 92-104 (2005)
39. Amir, R. E., et al. Rett syndrome is caused by mutations in X linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188 (1999)
40. Robertson, K. D., & Wolffe, A. P. DNA methylation in health and disease. Nat. Rev. Genet. 1, 11-19 (2000)
41. Prokhortchouk A., et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15, 1613-1618 (2001)
42. Rishi V., et al. CpG methylation of half-CRE sequences creates C/EBPa binding sites that activate some tissue-specific genes. Proc. Natl Acad. Sci. USA 107, 20311-20316 (2010)
43. Quenneville, S., et al. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol. Cell 44, 361-372 (2011)
44. Liu, Y., Toh, H., Sasaki, H., Zhang, X., & Cheng, X. An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence. Genes Dev. 26, 2374-2379 (2012)
45. Karlsson, Q. H., Schelcher, C., Verrall, E., Petosa, C., & Sinclair, A. J. Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog. 4, e1000005 (2008)
46. He, X., Futterer, J., & Hohn, T. Sequence-specific and methylation-dependent and-independent binding of rice nuclear proteins to a rice tungro bacilliform virus vascular bundle expression element. J. Biol. Chem. 276, 2644-2651 (2001)
47. Bahar Halpern, K., Vana, T., & Walker, M. D. Paradoxical role of DNA methylation in activation of FoxA2 gene expression during endoderm development. J. Biol. Chem. 289, 23882-23892 (2014)
48. Hantusch, B., Kalt, R., Krieger, S., Puri, C., & Kerjaschki, D. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos 2 osteoblastic cells. BMC Mol. Biol. 8, 20 (2007)
49. Niesen, M. I., et al. Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX. J. Biol. Chem. 280, 38914-38922 (2005)
50. Bartke T., et al. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143, 470-484 (2010)
51. Spruijt C. G., et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013)
52. Hu S., et al. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139, 610-622 (2009)
53. Hu S., et al. DNA methylation presents distinct binding sites for human transcription factors. eLife 2, e00726 (2013)
54. Badis G., et al. Diversity and complexity in DNA recognition by transcription factors. Science 324, 1720-1723 (2009)
55. Berger M. F., et al. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 133, 1266-1276 (2008)
56. Mann I. K., et al. CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res. 23, 988-997 (2013)
57. Brinkman A. B., et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-Talk. Genome Res. 22, 1128-1138 (2012)
58. Statham A. L., et al. Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res. 22, 1120-1127 (2012)
59. Gao F., et al. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells. Genomics 103, 204-210 (2014)
60. Strogantsev R., et al. Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression. Genome Biol. 16, 112 (2015)
61. Yoon, H. G., Chan, D. W., Reynolds, A. B., Qin, J., & Wong, J. N CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12, 723-734 (2003)
62. Lopes E. C., et al. Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Res. 68, 7258-7263 (2008)
63. Qin, S., et al. Kaiso mainly locates in the nucleus in vivo and binds to methylated, but not hydroxymethylated DNA. Chin. J. Cancer Res. 27, 148-155 (2015)
64. Blattler A., et al. ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes. Epigenetics Chromatin 6, 13 (2013)
65. Thurman R. E., et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012)
66. Li, J. J., Jiang, C. R., Brown, J. B., Huang, H., & Bickel, P. J. Sparse linear modeling of next-generation mRNA sequencing (RNA-Seq) data for isoform discovery and abundance estimation. Proc. Natl Acad. Sci. USA 108, 19867-19872 (2011)
67. Bailey T. L., et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009)
68. Liu Y., et al. Structural basis for Klf4 recognition of methylated DNA. Nucleic Acids Res. 42, 4859-4867 (2014)
69. Dantas Machado A. C., et al. Evolving insights on how cytosine methylation affects protein-DNA binding. Brief. Funct. Genom. 14, 61-73 (2015)
70. He H. H., et al. Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification. Nat. Methods 11, 73-78 (2014)
71. Lazarovici A., et al. Probing DNA shape and methylation state on a genomic scale with DNase I. Proc. Natl Acad. Sci. USA 110, 6376-6381 (2013)
72. Buck-Koehntop B. A., et al. Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc. Natl Acad. Sci. USA 109, 15229-15234 (2012)
73. Tippin, D. B., & Sundaralingam, M. Nine polymorphic crystal structures of d(CCGGGCCCGG), d(CCGGGCCm5CGG), d(Cm5CGGGCCm5CGG) and d(CCGGGCC(Br)5CGG) in three different conformations: effects of spermine binding and methylation on the bending and condensation of A DNA. J. Mol. Biol. 267, 1171-1185 (1997)
74. Chen X., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008)
75. Liu S., et al. Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach. MAbs. 7, 110-119 (2015)
76. Baubec, T., Ivanek, R., Lienert, F., & Schubeler, D. Methylation-dependent and-independent genomic targeting principles of the MBD protein family. Cell 153, 480-492 (2013)
77. Hon G. C., et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet. 45, 1198-1206 (2013)
78. Stadler M. B., et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490-495 (2011)
79. Charlet J., et al. Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers. Mol. Cell 62, 422-431 (2016)
80. Ohlsson, R., Renkawitz, R., & Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 17, 520-527 (2001)
81. Bell, A. C., & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482-485 (2000)
82. Schoenherr, C. J., Levorse, J. M., & Tilghman, S. M. CTCF maintains differential methylation at the Igf2/H19 locus. Nat. Genet. 33, 66-69 (2003)
83. Krebs, A. R., Dessus-Babus, S., Burger, L., & Schubeler, D. High-Throughput engineering of a mammalian genome reveals building principles of methylation states at CG rich regions. eLife 3, e04094 (2014)
84. Han, L., Lin, I. G., & Hsieh, C. L. Protein binding protects sites on stable episomes and in the chromosome from de novo methylation. Mol. Cell. Biol. 21, 3416-3424 (2001)
85. Fujiki K., et al. PPAR-induced PARylation promotes local DNA demethylation by production of 5 hydroxymethylcytosine. Nat. Commun. 4, 2262 (2013)
86. Sato, N., Kondo, M., & Arai, K. The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct 3/4 silencing. Biochem. Biophys. Res. Commun. 344, 845-851 (2006)
87. Tate, P. H., & Bird, A. P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226-231 (1993)
88. Bednarik D. P., et al. DNA CpG methylation inhibits binding of NF kappa B proteins to the HIV 1 long terminal repeat cognate DNA motifs. New Biol. 3, 969-976 (1991)
89. Comb, M., & Goodman, H. M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP 2. Nucleic Acids Res. 18, 3975-3982 (1990)
90. Ehrlich, K. C., Cary, J. W., & Ehrlich, M. A broad bean cDNA clone encoding a DNA-binding protein resembling mammalian CREB in its sequence specificity and DNA methylation sensitivity. Gene 117, 169-178 (1992)
91. Falzon, M., & Kuff, E. L. Binding of the transcription factor EBP 80 mediates the methylation response of an intracisternal A particle long terminal repeat promoter. Mol. Cell. Biol. 11, 117-125 (1991)
92. Iguchi-Ariga, S. M., & Schaffner, W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3, 612-619 (1989)
93. Inamdar, N. M., Ehrlich, K. C., & Ehrlich, M. CpG methylation inhibits binding of several sequence-specific DNA-binding proteins from pea, wheat, soybean and cauliflower. Plant Mol. Biol. 17, 111-123 (1991)
94. Kovesdi, I., Reichel, R., & Nevins, J. R. Role of an adenovirus E2 promoter binding factor in E1A mediated coordinate gene control. Proc. Natl Acad. Sci. USA 84, 2180-2184 (1987)
95. Prendergast, G. C., Lawe, D., & Ziff, E. B. Association of Myn, the murine homolog of max, with c Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65, 395-407 (1991)
96. Maurano M. T., et al. Role of DNA methylation in modulating transcription factor occupancy. Cell Rep. 12, 1184-1195 (2015)
97. Domcke S., et al. Competition between DNA methylation and transcription factors determines binding of NRF1. Nature 528, 575-579 (2015)
98. Blattler, A., & Farnham, P. J. Cross-Talk between site-specific transcription factors and DNA methylation states. J. Biol. Chem. 288, 34287-34294 (2013)
99. Baylin, S. B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2, S4-S11 (2005)
100. Yu D. H., et al. Developmentally programmed 3 CpG island methylation confers tissue-And cell-Type-specific transcriptional activation. Mol. Cell. Biol. 33, 1845-1858 (2013)
101. Wan J., et al. Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation. BMC Genomics 16, 49 (2015)
102. Kornberg, R. D. Chromatin structure: a repeating unit of histones and DNA. Science 184, 868-871 (1974)
103. Mikkelsen T. S., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007)
104. Ho, L., & Crabtree, G. R. Chromatin remodelling during development. Nature 463, 474-484 (2010)
105. Iwafuchi-Doi, M., & Zaret, K. S. Pioneer transcription factors in cell reprogramming. Genes Dev. 28, 2679-2692 (2014)
106. Zaret, K. S., & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241 (2011)
107. Soufi A., et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015)
108. Bossard, P., & Zaret, K. S. GATA transcription factors as potentiators of gut endoderm differentiation. Development 125, 4909-4917 (1998)
109. Laverriere, A. C., et al. GATA 4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J. Biol. Chem. 269, 23177-23184 (1994)
110. Liu, J. K., DiPersio, C. M., & Zaret, K. S. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol. Cell. Biol. 11, 773-784 (1991)
111. Buganim, Y., Faddah, D. A., & Jaenisch, R. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 14, 427-439 (2013)
112. Shukla S., et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 479, 74-79 (2011)
113. Maunakea, A. K., Chepelev, I., Cui, K., & Zhao, K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 23, 1256-1269 (2013)
114. Lyko F., et al. The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol. 8, e1000506 (2010)
115. Wan J., et al. Integrative analysis of tissue-specific methylation and alternative splicing identifies conserved transcription factor binding motifs. Nucleic Acids Res. 41, 8503-8514 (2013)
116. Noushmehr H., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 (2010)
117. Flavahan W. A., et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature (2015)
118. Parsons, D. W., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008)
119. Yan H., et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773 (2009)
120. Cairns, R. A., & Mak, T. W. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 3, 730-741 (2013)
121. Dang L., et al. Cancer-Associated IDH1 mutations produce 2 hydroxyglutarate. Nature 462, 739-744 (2009)
122. Xu W., et al. Oncometabolite 2 hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17-30 (2011)
123. Turcan S., et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479-483 (2012)
124. Guo, J. U., et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 17, 215-222 (2014)
125. Schultz M. D., et al. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature 523, 212-216 (2015)
126. Gabel H. W., et al. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522, 89-93 (2015)
127. Kinde, B., Gabel, H. W., Gilbert, C. S., Griffith, E. C., & Greenberg, M. E. Reading the unique DNA methylation landscape of the brain: non-CpG methylation, hydroxymethylation, and MeCP2. Proc. Natl Acad. Sci. USA 112, 6800-6806 (2015)
128. Kriaucionis, S., & Heintz, N. The nuclear DNA base 5 hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009)
129. Tahiliani M., et al. Conversion of 5 methylcytosine to 5 hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009)
130. Ito S., et al. Tet proteins can convert 5 methylcytosine to 5 formylcytosine and 5 carboxylcytosine. Science 333, 1300-1303 (2011)
131. Pfaffeneder T., et al. The discovery of 5 formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed Engl. 50, 7008-7012 (2011)
132. He Y. F., et al. Tet-mediated formation of 5 carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011)
133. Maiti, A., & Drohat, A. C. Thymine DNA glycosylase can rapidly excise 5 formylcytosine and 5 carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286, 35334-35338 (2011)
134. Yu M., et al. Base-resolution analysis of 5 hydroxymethylcytosine in the mammalian genome. Cell 149, 1368-1380 (2012)
135. Sun Z., et al. A sensitive approach to map genome-wide 5 hydroxymethylcytosine and 5 formylcytosine at single-base resolution. Mol. Cell 57, 750-761 (2015)
136. Shen L., et al. Genome-wide analysis reveals TET-And TDG-dependent 5 methylcytosine oxidation dynamics. Cell 153, 692-706 (2013)
137. Song C. X., et al. Genome-wide profiling of 5 formylcytosine reveals its roles in epigenetic priming. Cell 153, 678-691 (2013)
138. Booth M. J., et al. Quantitative sequencing of 5 methylcytosine and 5 hydroxymethylcytosine at single-base resolution. Science 336, 934-937 (2012)
139. Neri F., et al. Single-base resolution analysis of 5 formyl and 5 carboxyl cytosine reveals promoter DNA methylation dynamics. Cell Rep. (2015)
140. Wu, H., Wu, X., Shen, L., & Zhang, Y. Single-base resolution analysis of active DNA demethylation using methylase-Assisted bisulfite sequencing. Nat. Biotechnol. 32, 1231-1240 (2014)
141. Xia, B., et al. Bisulfite-free, base-resolution analysis of 5 formylcytosine at the genome scale. Nat. Methods 12, 1047-1050 (2015)
142. Iurlaro M., et al. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 14, R119 (2013)
143. Khrapunov S., et al. Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity. Biochemistry 53, 3379-3391 (2014)
144. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430 (2012)
145. Valinluck V., et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 4100-4108 (2004).